Originally published In Press as doi:10.1074/jbc.M105921200 on April 17, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22547-22552, June 21, 2002
Evidence for a Transition State Analog, MgADP-Aluminum
Fluoride-Acetate, in Acetate Kinase from Methanosarcina
thermophila*
Rebecca D.
Miles,
Andrea
Gorrell, and
James G.
Ferry
From the Department of Biochemistry and Molecular Biology, The
Pennsylvania State University, University
Park, Pennsylvania 16802-4500
Received for publication, June 26, 2001, and in revised form, April 15, 2002
 |
ABSTRACT |
Aluminum fluoride has become an important tool
for investigating the mechanism of phosphoryl transfer, an essential
reaction that controls a host of vital cell functions. Planar
AlF3 or AlF
molecules are proposed
to mimic the phosphoryl group in the catalytic transition state.
Acetate kinase catalyzes phosphoryl transfer of the ATP
-phosphate
to acetate. Here we describe the inhibition of acetate kinase from
Methanosarcina thermophila by preincubation with
MgCl2, ADP, AlCl3, NaF, and acetate.
Preincubation with butyrate in place of acetate did not significantly
inhibit the enzyme. Several NTPs can substitute for ATP in the
reaction, and the corresponding NDPs, in conjunction with
MgCl2, AlCl3, NaF, and acetate, inhibit acetate
kinase activity. Fluorescence quenching experiments indicated an
increase in binding affinity of acetate kinase for MgADP in the
presence of AlCl3, NaF, and acetate. These and other
characteristics of the inhibition indicate that the transition state
analog, MgADP-aluminum fluoride-acetate, forms an abortive complex in
the active site. The protection from inhibition by a non-hydrolyzable
ATP analog or acetylphosphate, in conjunction with the strict
dependence of inhibition on the presence of both ADP and acetate,
supports a direct in-line mechanism for acetate kinase.
 |
INTRODUCTION |
Acetate kinase, which catalyzes the phosphoryl transfer of the ATP
-phosphate to acetate, was one of the earliest phosphoryl transfer
enzymes to be recognized. Since the discovery of acetate kinase in 1944 by Lipmann (1) and isolation in 1954 by Ochoa (2), most research on the
catalytic mechanism has been performed with the Escherichia
coli enzyme. The early research led to two proposed catalytic
mechanisms, a triple-displacement mechanism via a covalent
phosphoenzyme intermediate and a direct in-line mechanism. The direct
in-line transfer mechanism is consistent with steady state kinetics (3)
and also stereochemical evidence (4), which indicates that there are an
odd number of in-line phosphoryl transfers (5, 6). The triple
displacement mechanism was proposed when a phosphoenzyme was reported
after incubation with radiolabeled ATP or acetylphosphate (7), and this
phophoenzyme was found to be chemically competent to transfer the
phosphoryl group to ADP or acetate (7). However, the triple
displacement mechanism was challenged when it was shown that
phosphorylated acetate kinase from E. coli is a phosphoryl
donor to Enzyme I of the bacterial phosphotransferase system, which
suggested an alternate function for phosphorylated acetate kinase in
sugar transport (8). There has been very little mechanistic work on
acetate kinase, since this intriguing triple displacement mechanism was
proposed by Spector in 1980 (5).
The thermostable Methanosarcina thermophila acetate kinase
has been cloned and hyper-produced in E. coli making it the
first available for modern biochemical approaches including
site-directed mutagenesis (9-11) and a crystal structure (12). The
crystal structure identifies acetate kinase as a member of the
superfamily now identified as the acetate and sugar kinases/Hsc70/actin
(ASKHA) superfamily (12, 13). Glucose binding to hexokinase results in
partial closure of the active site cleft and the subsequent binding of
ATP is proposed to result in even greater closure of the cleft (14,
15). When glucose is absent, the phosphates and metal of the
metal-nucleotide complex are proposed to be disordered possibly to
reduce the inherent ATPase activity of hexokinase (14-16). Acetate
kinase is expected to undergo an analogous conformational change upon
substrate binding. Consistent with this hypothesis, the
-phosphate
appears to be displaced in the current crystal structure of acetate
kinase in complex with ADP (12); hence, identification of residues
involved in catalysis from the crystal structure is precluded. Thus, a
crystal structure of acetate kinase in the transition state bound to
both MgADP and acetate as well as an analog of the
-phosphoryl group
of ATP is key to the identification of residues involved in transition
state stabilization and the orientation of the substrates for catalysis.
Aluminum fluoride has recently become a powerful tool in the study of
phosphoryl transfer enzymes. In several phosphatases and kinases,
AlF3-4 mimics the planar phosphoryl group in the catalytic
transition state (17-19). Here we present evidence for a transition
state analog, MgADP-aluminum fluoride-acetate, for the M. thermophila acetate kinase. To our knowledge, this work represents
the first use of aluminum fluoride to mimic a transition state in an
acetate kinase or in any kinase from the ASKHA superfamily. In
conjunction with recent site-directed replacement studies, our results
favor a direct in-line transfer of the ATP-
-phosphoryl group to
acetate and provide a new direction in which to investigate other
unanswered questions regarding the mechanism of acetate kinase.
 |
EXPERIMENTAL PROCEDURES |
Chemicals--
The following chemicals were of the highest
purity commercially available. Aluminum chloride hydrate, magnesium
chloride hexahydrate, sodium fluoride, and potassium hydroxide (for pH
adjustment) were purchased from Aldrich. The monopotassium salt of
adenosine 5'-diphosphate was purchased from Roche Molecular
Biochemicals. Potassium acetate, E. coli acetate kinase, and
BisTris1 were purchased from
Sigma. Sodium fluoride solutions were made and stored exclusively in
plastic containers. All reactions were performed in plastic tubes. The
remaining chemicals were of high purity. The sodium salts of inosine
5'-diphosphate, cytidine 5'-diphosphate, and propionic acid were
purchased from Sigma. The tetralithium salt of ATP
S (78% pure) and
the lithium potassium salt of acetylphosphate (90% pure) were also
from Sigma. The sodium salt of butyric acid was purchased from Aldrich.
Beryllium chloride was purchased from Alfa Aesar. The dipotassium salt
of bis-ANS was purchased from Molecular Probes.
Heterologous Production and Purification of the M. thermophila
Acetate Kinase--
Recombinant acetate kinase with a 6-residue
N-terminal histidine tag was heterologously produced in E. coli BL21(DE3) as described previously (10). The recombinant
acetate kinase was purified using a Ni-nitrilotriacetic acid silica
spin kit (Qiagen) according to manufacturer's instructions. The
enzymes were eluted in 50 mM
NaH2PO4 buffer (pH 7.0) containing NaCl (300 mM) and imidazole (250 mM). Protein
concentrations were determined by the Bradford method (20), using
protein dye reagent (Bio-Rad) and bovine serum albumin as the standard.
Enzyme Activity Assays--
Acetate kinase activity was
routinely determined with the hydroxamate assay (21), which detects the
formation of acetylphosphate from acetate and ATP. An enzyme-coupled
assay (21), in which ATP formation is linked to the reduction of NADP
through hexokinase and glucose-6-phosphate dehydrogenase, was used to
determine the Km value of ADP.
Inhibition of Enzyme Activity--
M. thermophila
acetate kinase (0.4 µM dimer) was preincubated in 100 mM BisTris buffer (pH 5.5) with MgCl2 (10 mM), ADP (10 mM), AlCl3 (0.1 mM), NaF (0.5 mM), and potassium acetate (25 mM) at ambient temperature for 30 min (200 µl total). A
portion of the preincubation mix (20 µl) was then assayed for
activity (350 µl total) unless otherwise noted. E. coli
acetate kinase (5 units) was preincubated and assayed in the same
manner as described for the M. thermophila enzyme.
Fluorescence Measurements--
A Hitachi F-2000 fluorescence
spectrophotometer was used to measure bis-ANS fluorescence. The
excitation and emission wavelengths were 390 and 500 nm, respectively.
Incubation mixes (1 ml total) contained the indicated concentrations of
MgADP, M. thermophila acetate kinase (0.4 µM
dimer), and bis-ANS (0.01 mM) in 100 mM BisTris
buffer (pH 5.5). When noted, AlCl3 (0.1 mM),
NaF (0.5 mM), and potassium acetate (25 mM)
were also present in the incubation mixes. Fluorescence intensities
were measured after a 2-h incubation at ambient temperature.
Initial Incubation with ATP
S or Acetylphosphate--
Acetate
kinase (0.4 µM dimer) was incubated with ATP
S (0.5-10
mM) or acetylphosphate (0.5-50 mM) in 100 mM BisTris buffer (pH 5.5) for 5 min at ambient temperature
(160 µl total). At the end of this initial incubation,
MgCl2 (10 mM), ADP (10 mM),
AlCl3 (0.1 mM), NaF (0.5 mM), and
potassium acetate (25 mM) were added to the reaction (200 µl total). The preincubation was allowed to proceed for another 30 min at ambient temperature before 20 µl of the preincubation mix was
assayed for acetate kinase activity (350 µl total).
 |
RESULTS |
Inhibition of M. thermophila Acetate Kinase by MgCl2,
ADP, AlCl3, NaF, and Acetate--
Preincubation with a
mixture of MgCl2, ADP, AlCl3, NaF, and acetate
inhibited the activity of acetate kinase from M. thermophila. The inhibition was dependent on the preincubation
time with a first-order rate constant of 0.24 ± 0.01 min
1 (Fig. 1). While this
inhibition rate is slower than expected for an enzyme-ligand
interaction, the rate can be attributed to the slow formation of
aluminum fluoride complexes as investigated previously (22). When
MgCl2, ADP, and acetate were omitted from the preincubation
mixture, there was no detectable loss of activity, indicating that
AlCl3 and NaF alone are not inhibitory (Fig. 1, inset). The results indicate that MgCl2, ADP,
AlCl3, NaF, and acetate are required for maximum inhibition
(Table I). There was a corresponding
decrease in enzyme activity as the concentration of each component of
the preincubation mixture was increased in the presence of fixed
concentrations of all other components (Fig. 2). Preincubation of acetate kinase with
MgCl2, ADP, acetate, and AlCl3 (1-100
µM) failed to inhibit enzyme activity (data not shown)
verifying fluoride-dependent inhibition and demonstrating AlCl3 is not inhibitory to the enzyme at the concentrations
tested. Replacement of AlCl3 with BeCl2 (1-200
µM) in the preincubation mix did not inhibit acetate
kinase activity (data not shown). The data for Fig. 2 were fit to an
analog of the Hill equation (Equation 1) (23),
|
(Eq. 1)
|
where i is percent inhibition,
imax is the maximum percent inhibition,
K
is the apparent inhibition
constant, [I] is the concentration of inhibitor, and n is the Hill coefficient (plots not shown). The apparent
K
was determined to be
2.9 ± 0.8 mM, 7-fold less than the previously reported Km value of 20 mM (21), and an
n value equal to 1.0 ± 0.1 was determined for acetate.
The apparent K
value was
determined to be 18.4 ± 0.7 µM, 130-fold less than
the experimental Km value of 2.4 mM
(21). The n value for NaF, was found to be 3.0 ± 0.8, suggesting three fluoride atoms are required for inhibition. The
apparent Ki values for magnesium and
AlCl3 were found to be 0.95 ± 0.02 mM and
3.4 ± 1.1 mM, respectively.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Inhibition of M. thermophila
acetate kinase by MgCl2, ADP, AlCl3, NaF,
and acetate. Acetate kinase (0.4 µM dimer) was
preincubated for the indicated times in a mixture containing
MgCl2 (10 mM), ADP (10 mM),
AlCl3 (0.1 mM), NaF (0.5 mM), and
potassium acetate (25 mM) in 100 mM BisTris
buffer (pH 5.5). The enzyme activity was then assayed and plotted
relative to 100% activity (600 µmol of acetylphosphate/min/mg of
protein) obtained from a control mixture in which AlCl3 and
NaF were omitted. Inset, the time course of the activity
assay after preincubation for 30 min with: complete inhibitory mixture
( ), minus NaF and AlCl3 ( ), minus MgCl2,
ADP and acetate ( ), minus all components except buffer ( ).
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Dose effects of MgCl2, ADP,
AlCl3, NaF, and acetate on inhibition of M. thermophila acetate kinase. A-E, acetate
kinase (0.4 µM dimer) was preincubated for 30 min with
MgCl2 (10 mM), ADP (10 mM),
AlCl3 (0.1 mM), NaF (0.5 mM), and
potassium acetate (25 mM) in 100 mM BisTris
buffer (pH 5.5) unless otherwise noted. The enzyme activity was then
assayed and plotted as described in the legend to Fig. 1.
|
|
ATP
S was tested as a substrate of acetate kinase and found to be a
non-hydrolyzable inhibitor (data not shown). Acetate kinase was
incubated with ATP
S or acetylphosphate before and during preincubation with MgCl2, ADP, AlCl3, NaF, and
acetate to determine whether ATP
S or acetylphosphate protected
against the inhibition. A corresponding decrease in the inhibition of
enzymatic activity was observed as the concentration of ATP
S (Fig.
3) or acetylphosphate (Fig.
4) increased. There was an apparent lag
in the relief of inhibition by ATP
S, while acetylphosphate
protection leveled off at 30% inhibition. One possibility for the lag
is that the ATP analog ATP
S binds the enzyme with a lower affinity
than ATP, thus affording less protection from the transition state
analog. The residual 30% inhibition can possibly be attributed to
turnover of the enzyme during preincubation with ADP and
acetylphosphate, which allowed for formation of the transition state
complex.

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 3.
Protection by ATP S
from inhibition of M. thermophila acetate kinase
activity. The enzyme (0.4 µM dimer) was incubated
with ATP S in 100 mM BisTris buffer (pH 5.5) for 5 min
before addition of MgCl2 (10 mM), ADP (10 mM), AlCl3 (0.1 mM), NaF (0.5 mM), and potassium acetate (25 mM). The enzyme
was then incubated for another 30 min at which time acetate kinase
activity was measured as described in the legend to Fig. 1.
|
|

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 4.
Protection by acetylphosphate from inhibition
of M. thermophila acetate kinase activity. The
enzyme (0.4 µM dimer) was incubated with acetylphosphate
in 100 mM BisTris buffer (pH 5.5) for 5 min before addition
of MgCl2 (10 mM), ADP (10 mM),
AlCl3 (0.1 mM), NaF (0.5 mM), and
potassium acetate (25 mM). The enzyme was then incubated
for another 30 min at which time acetate kinase activity was measured
as described in the legend to Fig. 1.
|
|
Effect of Alternative Substrates on the AlCl3 and
NaF-dependent Inhibition--
Several NTPs can replace ATP
for the M. thermophila enzyme. The reported specific
activities (µmol of acetylphosphate/min/mg of protein) with ATP, ITP,
UTP, or CTP are 412, 342, 330, and 218, respectively (21).
Preincubation of acetate kinase with MgCl2,
AlCl3, NaF, acetate, and either IDP, UDP, or CDP in place of ADP resulted in almost complete inhibition of activity (Table II). To determine the phosphoryl acceptor
requirements for formation of the inhibitory complex, acetate was
substituted with propionate or butyrate. Activity of the M. thermophila enzyme with propionate is 60% of that with acetate,
whereas butyrate is not a substrate (21). Preincubation with
MgCl2, ADP, AlCl3, NaF, and propionate resulted
in almost complete inhibition of activity; however, preincubation with
butyrate in place of acetate did not significantly inhibit the enzyme
(Table II).
Fluorescence Monitoring of MgADP Binding--
Buffered solutions
of either acetate kinase or bis-ANS had very low intrinsic
fluorescence; however, when these two components were incubated
together there was an ~20-fold enhancement of fluorescence indicative
of bound bis-ANS. The fluorescence quenching dependent on the MgADP
concentration was used to examine the MgADP binding to the acetate
kinase in the absence or presence of AlCl3, NaF, and
acetate (Fig. 5). When AlCl3,
NaF, and acetate were absent, the pattern of fluorescence quenching was
biphasic in response to increasing MgADP concentrations. A robust first
phase of fluorescence quenching below 10 µM MgADP was
followed by a weaker second phase at higher concentrations. There was a
similar pattern when AlCl3, NaF, and acetate were present;
however, the first phase was more pronounced than in the absence of
AlCl3, NaF, and acetate (Fig. 5). Two possible explanations
for the first phase of fluorescence quenching are: (i) a MgADP-induced
environment change around a bound bis-ANS molecule or (ii) displacement
of bound bis-ANS by MgADP. In favor of the latter mechanism, it has
been reported that bis-ANS binds to hydrophobic pockets and with
particularly high affinity to nucleotide binding sites (24, 25).
Although the results do not distinguish between these two
possibilities, the first phase of fluorescence quenching most likely
reflects nucleotide binding at the high affinity catalytic site. The
weaker second phase may be attributed to a nonspecific site that binds bis-ANS and has low affinity for MgADP. Consequently, the first phase
of fluorescence quenching was used to examine MgADP binding affinity.
The results indicate an increase in binding affinity of acetate kinase
for MgADP in the presence of AlCl3, NaF, and acetate. When
either acetate or AlCl3 plus NaF were omitted from the
reaction mixture, the pattern of fluorescence quenching was similar to
that observed in the absence of all three of these components (data not
shown). This result suggests that the increase in binding affinity for
MgADP is dependent on the presence of AlCl3, NaF, and
acetate but not AlCl3 plus NaF alone or acetate alone.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 5.
Binding of MgADP to the M. thermophila acetate kinase. The enzyme (0.4 µM dimer) was incubated with the fluorescent probe
bis-ANS (0.01 mM) and the indicated concentrations of MgADP
for 2 h with ( ) or without ( ) AlCl3 (0.1 mM), NaF (0.5 mM), and potassium acetate (25 mM) in 100 mM BisTris buffer (pH 5.5). The
excitation and emission wavelengths were 390 and 500 nm, respectively.
The decreases in the fluorescence intensity (arbitrary units) at each
MgADP concentration, relative to the fluorescence intensity of a sample
containing no MgADP, are indicated as absolute values.
|
|
Inhibition of E. coli Acetate Kinase by MgCl2, ADP,
AlCl3, NaF, and Acetate--
E. coli acetate
kinase activity was fully inhibited by the mixture of
MgCl2, ADP, AlCl3, NaF, and acetate (Table I)
using the same experimental conditions as for the M. thermophila enzyme. The E. coli enzyme retained 80% or
higher activity when each component was individually omitted from the
preincubation mixture (Table I), indicating that all of the components
are necessary for maximum inhibition.
 |
DISCUSSION |
Studies on several kinases including F1-ATPase and UMP
kinase indicate that AlF3-4 mimics the planar phosphoryl
group in the catalytic transition state and, with the substrates, forms an abortive active site complex (17, 19). Here we report the inhibition
of M. thermophila acetate kinase activity by
MgCl2, ADP, AlCl3, NaF, and acetate. The
characteristics of the inhibition and other experiments indicate that a
transition state analog, MgADP-aluminum fluoride-acetate, forms an
abortive complex in the active site of acetate kinase.
The requirements for formation of a transition state analog should
mimic the requirements for catalysis. If MgADP-aluminum fluoride-acetate is a transition state analog for the acetate kinase,
then any substrate that substitutes for acetate should form a
transition state analog in conjunction with MgCl2, ADP, AlCl3, and NaF. Propionate replaces acetate as a substrate
(21), and as shown here inhibited the enzyme when preincubated with MgCl2, ADP, AlCl3, NaF; however, butyrate is
not a substrate for acetate kinase (21) and did not form an inhibitory
complex with MgCl2, ADP, AlCl3, and NaF. These
results support MgADP-aluminum fluoride-acetate as a transition state
analog. A distinguishing characteristic of acetate kinase is the
ability to utilize various NTPs (21) in place of ATP. Each of the
cognate NDPs (in conjunction with MgCl2, ADP,
AlCl3, NaF, and acetate) resulted in the inhibition of
acetate kinase activity, further supporting the formation of a
transition state analog. These results also indicate that inhibition of
acetate kinase is not the consequence of a nonspecific interaction of
aluminum fluoride with the adenosine moiety of ADP to form an inactive
nucleotide complex. Although ADP is not a
-phosphoryl group donor in
the acetate kinase reaction, AMP was able to partially replace ADP in
the proposed transition state analog. AMP has previously been shown to
be a competitive inhibitor versus ATP in the E. coli acetate kinase (Ki of 7.4 mM)
(26). MgAMP, aluminum fluoride, and acetate may form a transition state
analog despite the absence of the
-phosphate. Either the nucleotide
-phosphate group is not essential for formation of the active
conformation of acetate kinase or aluminum fluoride substitutes for
both the nucleotide
- and
-phosphates in the MgAMP-aluminum
fluoride-acetate complex. The ability of MgCl2, ADP,
AlCl3, NaF, and acetate to inhibit acetate kinases from
both E. coli (Bacteria domain) and phylogenetically distant
M. thermophila (Archaea domain) indicates that the
inhibition is related to the common mechanism of catalysis and not a
nonspecific event.
Although not always observed, the propensity of enzymes to maximize
protein-substrate interactions in the transition state predicts tighter
binding of substrates. The fluorescence quenching results indicate that
acetate kinase has a higher binding affinity for MgADP when
AlCl3, NaF, and acetate are present. Consistent with these
results are the much lower Ki values determined for
ADP and acetate (in the presence of MgCl2,
AlCl3, NaF, and the co-substrate) relative to the
Km values for ADP and acetate. In conclusion, the
fluorescence and Ki data are consistent with the
formation of a transition state analog, MgADP-aluminum
fluoride-acetate.
The primary metal complexes involved in acetate kinase inhibition were
MgADP and aluminum fluoride; however, the 23% inhibition of acetate
kinase by the preincubation mixture minus AlCl3 suggests the formation of magnesium fluoride, which is also inhibitory. In
support of this scenario, magnesium fluoride, in addition to aluminum
fluoride, is proposed to form in the transition state analog of G
proteins (27). Consequently, a portion of the metal fluoride in the
acetate kinase transition state analog is probably magnesium fluoride.
The dependence of acetate kinase inhibition on the AlCl3
concentration suggests the predominant metal fluoride species in the
transition state analog is aluminum fluoride (28). Beryllium failed to
replace aluminum in the inhibitory complex. Beryllium fluoride, in
association with a bridging
-phosphate oxygen, is thought to mimic
the tetrahedral nucleotide
-phosphate in the ground state (29, 30).
Consequently, beryllium fluoride is not a true analog of the planar
phosphoryl group during catalysis. Despite this fact, preincubation
with MgADP, BeCl2, and NaF inhibits several phosphoryl
transfer enzymes, including adenylate kinase and F1-ATPase
(17, 31). Acetate kinase may differ from these enzymes in the inability
to form a locked active conformation without a planar phosphoryl analog
in the inhibitory complex.
The stoichiometry of the aluminum fluoride complex that forms in
acetate kinase is uncertain. It has been proposed that pH plays a
significant role in the aluminum to fluoride ratio of the transition
state analog (32). The acetate kinase was inhibited in a preincubation
mixture containing MgCl2, ADP, AlCl3, NaF, and
acetate at a pH value of 5.5. At this pH, AlF
is
proposed to be the dominant species in the transition state analogs of
kinases (32) and thus may be the species formed in acetate kinase. A
planar AlF
molecule would not strictly mimic the
planar phosphoryl group during catalysis. Nevertheless, transition
state analogs containing AlF
have been shown to be
reasonable mimics of the transition state (29, 33, 34). The nature of
the nucleophilic attack may also help to determine the aluminum
fluoride species in the transition state analog (30). Crystal
structures of G
i (33) and G
t GTPases (34), as well as myosin (29), indicate that an octahedrally coordinated aluminum is present in the transition state analog with
four equatorial fluoride atoms, a nucleotide
-phosphate oxygen as
one apical ligand, and a water molecule as the second apical ligand.
Hydrolytic nucleotidases such as these may have more structural
flexibility to accept AlF
than would enzymes that
utilize a protein functional group as the nucleophile (30). In
nucleoside diphosphate kinase for example, in which an active site
histidine attacks the
-phosphate, steric considerations were invoked
to explain the presence of AlF3 instead of
AlF
in the crystal structure (30). If the above
scenario is correct, the requirement for acetate in the proposed
acetate kinase transition state analog suggests that this molecule acts
as the nucleophile and further suggests that the aluminum fluoride
species is AlF3, not AlF
. This
supposition is supported by a binding coefficient of ~3 that was
determined for NaF in formation of the inhibitory complex.
Since the 1970s, there has been dispute over a single versus
triple displacement mechanism for acetate kinase. The single displacement mechanism assumes direct in-line phosphoryl transfer from
ATP to acetate, whereas the triple displacement mechanism involves
phosphoryl transfer to two enzyme sites before transfer to acetate.
Here we report the requirement for both ADP and acetate in formation of
the transition state analog. The most straightforward interpretation of
these results is that the phosphorylation of acetate by ATP occurs by a
direct in-line mechanism. The protection from inhibition by
non-hydrolyzable ATP
S or acetylphosphate suggests that the terminal
phosphate of ATP, the phosphate group of acetylphosphate, and the
aluminum fluoride of the transition state analog all share the same
binding site. These results are consistent with a direct in-line
mechanism. Other recent site-directed mutagenesis studies reported for
the M. thermophila enzyme support the direct in-line mechanism. These studies have eliminated the possibility of active site
histidine residues acting as phosphorylation sites in the catalytic
mechanism (11). In addition, active site residues Arg91 and
Arg241 were found to be essential for catalysis (10). These
arginines are well positioned in the crystal structure to stabilize the transition state in a direct in-line mechanism (12). If the acetate
kinase reaction involves a direct in-line phosphoryl transfer, an
alternative role must be proposed for active site residue
Glu384, previously found to be essential for catalysis and
postulated as the phosphorylation site of acetate kinase (9). Instead of acting as a catalytic phosphorylation site, Glu384 may
be involved in magnesium binding. In support of this proposal, variant
Glu384
Ala requires a 30-fold increase in the
concentration of magnesium necessary for half-maximal velocity relative
to that of the wild-type enzyme (35). Thus, the results presented here
combined with recent reports support a direct in-line mechanism.
Finally, the work presented here lays the foundation for further
research to elucidate the role of active site residues and the
catalytic mechanism for this enzyme.
 |
ACKNOWLEDGEMENTS |
We thank Allen Phillips and Cheryl
Ingram-Smith for suggestions on the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant GM44661.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, The Pennsylvania State University, 205 S. Frear,
University Park, PA 16802-4500. Tel.: 814-863-5721; Fax: 814-863-6217;
E-mail: jgf3@psu.edu.
Published, JBC Papers in Press, April 17, 2002, DOI 10.1074/jbc.M105921200
 |
ABBREVIATIONS |
The abbreviations used are:
BisTris, bis(2-hydroxyethyl)imino-tris(hydroxymethyl)methane;
ATP
S, adenosine
5'-O-(3-thiotriphosphate);
bis-ANS, 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid.
 |
REFERENCES |
| 1.
|
Lipmann, F.
(1944)
J. Biol. Chem.
155,
55-70[Free Full Text]
|
| 2.
|
Rose, I. A.,
Grunberg-Manago, M.,
Korey, S. R.,
and Ochoa, S.
(1954)
J. Biol. Chem.
211,
737-756[Free Full Text]
|
| 3.
|
Janson, C. A.,
and Cleland, W. W.
(1974)
J. Biol. Chem.
249,
2567-2571[Abstract/Free Full Text]
|
| 4.
|
Blattler, W. A.,
and Knowles, J. R.
(1979)
Biochemistry
18,
3927-3933[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Spector, L. B.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
2626-2630[Abstract/Free Full Text]
|
| 6.
|
Todhunter, J. A.,
and Purich, D. L.
(1974)
Biochem. Biophys. Res. Commun.
60,
273-280[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Anthony, R. S.,
and Spector, L. B.
(1972)
J. Biol. Chem.
247,
2120-2125[Abstract/Free Full Text]
|
| 8.
|
Fox, D. K.,
Meadow, N. D.,
and Roseman, S.
(1986)
J. Biol. Chem.
261,
13498-13503[Abstract/Free Full Text]
|
| 9.
|
Singh-Wissmann, K.,
Ingram-Smith, C.,
Miles, R. D.,
and Ferry, J. G.
(1998)
J. Bacteriol.
180,
1129-1134[Abstract/Free Full Text]
|
| 10.
|
Singh-Wissmann, K.,
Miles, R. D.,
Ingram-Smith, C.,
and Ferry, J. G.
(2000)
Biochemistry
39,
3671-3677[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Ingram-Smith, C.,
Barber, R. D.,
and Ferry, J. G.
(2000)
J. Biol. Chem.
275,
33765-33770[Abstract/Free Full Text]
|
| 12.
|
Buss, K. A.,
Cooper, D. R.,
Ingram-Smith, C.,
Ferry, J. G.,
Sanders, D. A.,
and Hasson, M. S.
(2001)
J. Bacteriol.
183,
680-686[Abstract/Free Full Text]
|
| 13.
|
Buss, K. A.,
Ingram-Smith, C.,
Ferry, J. G.,
Sanders, D. A.,
and Hasson, M. S.
(1997)
Protein Sci.
6,
2659-2662[Abstract]
|
| 14.
|
Steitz, T. A.,
Shoham, M.,
and Bennet, W. S. J.
(1981)
Philos. Trans. R. Soc. Lond. B Biol. Sci.
293,
43-52[Medline]
[Order article via Infotrieve]
|
| 15.
|
Shoham, M.,
and Steitz, T. A.
(1980)
J. Mol. Biol.
140,
1-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Zeng, C.,
Aleshin, A. E.,
Hardie, J. B.,
Harrison, R. W.,
and Fromm, H. J.
(1996)
Biochemistry
35,
13157-13164[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Lunardi, J.,
Dupuis, A.,
Garin, J.,
Issartel, J.-P.,
Michel, L.,
Chabre, M.,
and Vignais, P. V.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
8958-8962[Abstract/Free Full Text]
|
| 18.
|
Nadanaciva, S.,
Weber, J.,
and Senior, A. E.
(1999)
J. Biol. Chem.
274,
7052-7058[Abstract/Free Full Text]
|
| 19.
|
Schlichting, I.,
and Reinstein, J.
(1997)
Biochemistry
36,
9290-9296[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Aceti, D. J.,
and Ferry, J. G.
(1988)
J. Biol. Chem.
263,
15444-15448[Abstract/Free Full Text]
|
| 22.
|
Antonny, B.,
and Chabre, M.
(1992)
J. Biol. Chem.
267,
6710-6718[Abstract/Free Full Text]
|
| 23.
|
Scrutton, M. C.,
and Utter, M. F.
(1965)
J. Biol. Chem.
240,
3714-3723[Free Full Text]
|
| 24.
|
Secnik, J.,
Gelfand, C. A.,
and Jentoft, J. E.
(1992)
Biochemistry
31,
2982-2988[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Takashi, R.,
Tonomura, Y.,
and Morales, M. F.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
2334-2338[Abstract/Free Full Text]
|
| 26.
|
Purich, D. L.,
and Fromm, H. J.
(1972)
Arch. Biochem. Biophys.
149,
307-315[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Graham, D. L.,
Eccleston, J. F.,
Chung, C.-W.,
and Lowe, P. N.
(1999)
Biochemistry
38,
14981-14987[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Issartel, J. P.,
Dupuis, A.,
Lunardi, J.,
and Vignais, P. V.
(1991)
Biochemistry
30,
4726-4733[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Fisher, A. J.,
Smith, C. A.,
Thoden, J. B.,
Smith, R.,
Sutoh, K.,
Holden, H. M.,
and Rayment, I.
(1995)
Biochemistry
34,
8960-8972[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Xu, Y. W.,
Morera, S.,
Janin, J.,
and Cherfils, J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
3579-3583[Abstract/Free Full Text]
|
| 31.
|
Garin, J.,
and Vignais, P. V.
(1993)
Biochemistry
32,
6821-6827[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Schlichting, I.,
and Reinstein, J.
(1999)
Nat. Struct. Biol.
6,
721-723[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Coleman, D. E.,
Berghuis, A. M.,
Lee, E.,
Linder, M. E.,
Gilman, A. G.,
and Sprang, S. T.
(1994)
Science
265,
1405-1412[Abstract/Free Full Text]
|
| 34.
|
Sondek, J.,
Lambright, D. G.,
Noel, J. P.,
Hamm, H. E.,
and Sigler, P. B.
(1994)
Nature
372,
276-279[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Miles, R. D.,
Iyer, P. P.,
and Ferry, J. G.
(2001)
J. Biol. Chem.
276,
45059-45064[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Ingram-Smith, A. Gorrell, S. H. Lawrence, P. Iyer, K. Smith, and J. G. Ferry
Characterization of the Acetate Binding Pocket in the Methanosarcina thermophila Acetate Kinase
J. Bacteriol.,
April 1, 2005;
187(7):
2386 - 2394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gorrell, S. H. Lawrence, and J. G. Ferry
Structural and Kinetic Analyses of Arginine Residues in the Active Site of the Acetate Kinase from Methanosarcina thermophila
J. Biol. Chem.,
March 18, 2005;
280(11):
10731 - 10742.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.